SCHEMBL6403134

SCHEMBL6403134

C[C@@H]1CN(C(=O)OCCC2CCNCC2)C[C@H](C)O1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 2/20 0.36
TPSD1 Q9BZJ3 2/20 0.36
TPSG1 Q9NRR2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
CYP2C19 P33261 1/20 0.36
GNAI3 P08754 1/20 0.36
GNAO1 P09471 1/20 0.36
GNAI1 P63096 1/20 0.36
PDK1 Q15118 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
ITGB3 P05106 3/20 0.35
ITGA2B P08514 3/20 0.35
FKBP1A P62942 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
F2R P25116 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6403138 1.00 TPSAB1 (0.36) TPSAB1TPSD1TPSG1ALDH1A1HPGD
SCHEMBL6152753 0.80 TPSAB1 (0.43) TPSAB1TPSD1TPSG1ALDH1A1GNAI3
SCHEMBL6407001 0.79 GPR119 (0.47)
SCHEMBL6407004 0.79 GPR119 (0.47)
SCHEMBL6152693 0.78 ALDH1A1 (0.48) TPSAB1TPSD1TPSG1ALDH1A1GNAI3
SCHEMBL4093465 0.78 MEN1 (0.38) ALDH1A1HPGDCYP2C19PDK1CHRNB2
SCHEMBL4093461 0.78 MEN1 (0.38) ALDH1A1HPGDCYP2C19PDK1CHRNB2
Hydrochloric Acid SCHEMBL6152281 0.77 TPSAB1 (0.48) TPSAB1TPSD1TPSG1GNAI3GNAO1
Hydrochloric Acid SCHEMBL6149800 0.76 TPSAB1 (0.45) TPSAB1TPSD1TPSG1ALDH1A1GNAI3
SCHEMBL6150351 0.73 TPSAB1 (0.45) TPSAB1TPSD1TPSG1ALDH1A1GNAI3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143391-A1 Heterocyclic amides with alpha-4 integrin antagonist activity J. Uriach Y Compañia S.A. (ES) 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143391-A1 Heterocyclic amides with alpha-4 integrin antagonist activity ITGB4, ITGA4, ITGA1 TPSAB1 113/4885TPSD1 613/4885TPSG1 996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.